2 results
Approved WMOCompleted
The aim of this study is to validate a clinical VLE prediction score and to develop a VLE computer algorith that could improve detection of early neoplasie in BE patients.
Approved WMOCompleted
PrimaryTo evaluate confirmed ORR of Trastuzumab deruxtecan in human epidermal growth factor receptor 2- (HER2-) mutated NSCLC subjects treated at 5.4 and 6.4 mg/kg doses.Secundary- To evaluate the clinical efficacy of Trastuzumab deruxtecan at 5.4…